National Cancer Centre, Singapore: all 116 studies

Page 1 of 2. Open to participants first (29), then studies with results posted, then the rest; newest registration first within each.

• Mailed FIT-Based Outreach InterventionsNot yet recruitingNCT07852793Not applicable
• Effectiveness and Implementation of 'Supportive and Palliative Care Review Kit in Locations Everywhere'Not yet recruitingNCT07745816Not applicable
• Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With CancerNot yet recruitingNCT07733973Not applicable
• Electroacupuncture for Cognitive Toxicity in Cancer Survivors: Assessing Implementation, Cost, and Effectiveness for IntegrationNot yet recruitingNCT07583979Phase 3
• Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)Not yet recruitingNCT07521670Phase 2
• Histotripsy for Ablation of Liver Tumours in AsiaRecruitingNCT07428356Not applicable
• Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early DementiaRecruitingNCT07234357Not applicable
• Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in SingaporeRecruitingNCT07116161Not applicable
• Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver CancerNot yet recruitingNCT07111130Not applicable
• Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research ProposalRecruitingNCT06977360Not applicable
• Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE)RecruitingNCT06956248
• Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy.RecruitingNCT06766058Not applicable
• Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With ChemotherapyRecruitingNCT06587295Phase 1
• A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLCRecruitingNCT06418412
• Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative CareRecruitingNCT06244953Not applicable
• Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell LymphomaRecruitingNCT06160843Phase 2
• Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal CarcinomaRecruitingNCT06093061Phase 2
• Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)RecruitingNCT06044441Not applicable
• Breast Cancer Exercise Intervention StudyRecruitingNCT05957068Not applicable
• Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer PatientsRecruitingNCT05929885Phase 2
• SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)RecruitingNCT05724264Not applicable
• tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)RecruitingNCT05517135
• Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular CarcinomaRecruitingNCT05516628Phase 2
• Using QPOP to Predict Treatment for Sarcomas and MelanomasRecruitingNCT04986748
• Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRCRecruitingNCT04912765Phase 2
• Telegenetics or In-Person Genetic CounsellingRecruitingNCT04738708
• Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer PatientsRecruitingNCT04340024
• Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic AdenocarcinomaRecruitingNCT04303403Phase 1
• Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) ProjectRecruitingNCT02806388
• Increasing Uptake of Cascade Testing in Families With Familial Cancer Syndromes: A Randomized Controlled Trial of a Registry-aided Model.CompletedNCT07626814Not applicable
• Acceptability and Feasibility of PSC Model of Serious Illness CommunicationActive, not recruitingNCT07428655Not applicable
• Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast CancerTerminatedNCT07166367Phase 2
• Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCCCompletedNCT06294808
• Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff VolunteersCompletedNCT06194084Not applicable
• A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLCActive, not recruitingNCT05773092Phase 2
• PSMA-PET Imaging of Salivary Gland Tumours and Other Rare CancersCompletedNCT05581979
• Somatostatin Receptor Imaging in NPC, EBV Related CancersCompletedNCT05581550Not applicable
• Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC PatientsActive, not recruitingNCT05377034Phase 2
• A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix CancerStatus unknownNCT05355558Not applicable
• Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With LetrozoleActive, not recruitingNCT05286437Phase 2
• ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in SingaporeCompletedNCT05211882Not applicable
• Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-inSuspendedNCT05198479Phase 2
• Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular CarcinomaActive, not recruitingNCT05148572
• 18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning StudyCompletedNCT04995185Not applicable
• Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)Active, not recruitingNCT04965259
• Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376Active, not recruitingNCT04961632Phase 1
• Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical OutcomesCompletedNCT04961489
• PIPAC for Peritoneal MetastasesSuspendedNCT04956068Phase 1
• Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging BiomarkersActive, not recruitingNCT04946968Phase 2
• The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBCCompletedNCT04664829Phase 1
• Impact of a Breast cAncer Survivorship Interprofessional Community Care ModelCompletedNCT04660188Not applicable
• Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal OriginStatus unknownNCT04620954Phase 1/2
• Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRTCompletedNCT04452084Phase 2
• LiverMultiScan Analysis of MRI Scans in HCCCompletedNCT04451603
• Novel Palliative Care Model for Advanced Cancer Patients: A Randomized Controlled Trial StudyCompletedNCT04242251Not applicable
• Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell LymphomaWithdrawnNCT04230330Phase 1
• Longitudinal Immune-phenotyping of HCC Following MK-3475Active, not recruitingNCT04224480Phase 1
• Phase II Study of PRL3-ZUMAB in Advanced Solid TumorsCompletedNCT04118114Phase 2
• Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLCCompletedNCT04087473
• Phase 2 Study of Dacomitinib in NSCLCActive, not recruitingNCT04027647Phase 2
• Molecular Profiling ProjectSuspendedNCT04025515
• Window of Opportunity Study in Colorectal CancerCompletedNCT03984578Phase 2
• Radical Resection and HIPEC for Recurrent Retroperitoneal SarcomaActive, not recruitingNCT03792867Not applicable
• Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLCTerminatedNCT03711422Phase 1
• Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal CancerCompletedNCT03670342
• Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAOCompletedNCT03515174Not applicable
• Perioperative Immunonutrition for Patients Undergoing CRS and HIPECCompletedNCT03430128Not applicable
• Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer PatientsStatus unknownNCT03429972Phase 2
• Prophylactic HIPEC for Colorectal Cancers At High Risk of Developing Peritoneal MetastasesCompletedNCT03422432Not applicable
• Effectiveness of the Supportive and Palliative Care Review Kit (SPARK) for Cancer Patients in the Acute HospitalCompletedNCT03330509Not applicable
• Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular CarcinomaCompletedNCT03267641
• Hepatocellular Carcinoma Registry in Asia: The INSIGHT RegistryCompletedNCT03233360
• Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell LymphomaCompletedNCT03212937Phase 1
• Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal OriginTerminatedNCT03100006Phase 1/2
• Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal CarcinomaActive, not recruitingNCT03097939Phase 2
• Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Marginal Zone LymphomaTerminatedNCT03093831Phase 2
• Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung CancerTerminatedNCT03091491Phase 2
• Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular CarcinomaCompletedNCT03033446Phase 2
• Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell LymphomaTerminatedNCT02808091Phase 2
• PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker DiscoveryCompletedNCT02804776Phase 2
• Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung CancerCompletedNCT02801734Not applicable
• Use of Regorafenib in Recurrent Epithelial Ovarian CancerCompletedNCT02736305Phase 2
• Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric CancerTerminatedNCT02720926Phase 1
• Pilot Study of the SPaRK (Supportive and Palliative Care Review Kit) Model of Care for Advanced Cancer Patients Who Have an Unplanned Admission to Singapore General HospitalCompletedNCT02559336Not applicable
• ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With LeucovorinStatus unknownNCT02435927Phase 1
• Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)CompletedNCT02412267Phase 2
• Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc TherapyStatus unknownNCT02408497
• OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic AdenocarcinomaCompletedNCT02368860Phase 1
• Stereotactic Body Radiotherapy for Organ Confined Prostate CancerStatus unknownNCT02313298Phase 2
• A Study Into the Effect of Seprafilm in Open Total ThyroidectomyTerminatedNCT01865838Not applicable
• Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid SurgeryCompletedNCT01765686Not applicable
• A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric CancerCompletedNCT01736410Phase 2
• Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced SarcomasCompletedNCT01716689Phase 2
• A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFRCompletedNCT01570296Phase 1
• Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic AnalysesCompletedNCT01540110Phase 2
• Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast CancerTerminatedNCT01394315
• Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven TumorsStatus unknownNCT01341834Phase 1
• AZD6244 and Sorafenib in Advanced Hepatocellular CarcinomaTerminatedNCT01029418Phase 1/2
• Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor CellsStatus unknownNCT01022723
• Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPCStatus unknownNCT00997906Phase 2/3

← National Cancer Centre, Singapore overview and focus areas